7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Peri-Implantitis D057873 1 associated lipids
Adrenocortical Adenoma D018246 1 associated lipids
Hyperparathyroidism, Primary D049950 1 associated lipids
Breast Neoplasms, Male D018567 1 associated lipids
Severe Combined Immunodeficiency D016511 1 associated lipids
Fluorosis, Dental D009050 1 associated lipids
Hashimoto Disease D050031 1 associated lipids
POEMS Syndrome D016878 1 associated lipids
Fibroma, Ossifying D018214 1 associated lipids
Osteolysis, Essential D010015 1 associated lipids
Neoplasms, Squamous Cell D018307 1 associated lipids
Ankylosis D000844 1 associated lipids
Osteoporotic Fractures D058866 1 associated lipids
Hemangioma, Capillary D018324 1 associated lipids
Dentin Dysplasia D003805 1 associated lipids
Cleidocranial Dysplasia D002973 1 associated lipids
Histiocytosis, Langerhans-Cell D006646 1 associated lipids
Rheumatic Fever D012213 1 associated lipids
Chronic Periodontitis D055113 1 associated lipids
Intracranial Hemorrhage, Traumatic D020198 1 associated lipids
Neoplastic Syndromes, Hereditary D009386 1 associated lipids
Osteopetrosis D010022 1 associated lipids
Scleroderma, Limited D045745 1 associated lipids
Vestibulocochlear Nerve Diseases D000160 1 associated lipids
Dental Pulp Exposure D003789 1 associated lipids
Dental Occlusion, Traumatic D003769 1 associated lipids
Arthropathy, Neurogenic D001177 1 associated lipids
Giant Cell Tumor of Bone D018212 1 associated lipids
Rupture, Spontaneous D012422 1 associated lipids
Hemarthrosis D006395 1 associated lipids
Cherubism D002636 1 associated lipids
Hyperostosis D015576 1 associated lipids
Bisphosphonate-Associated Osteonecrosis of the Jaw D059266 1 associated lipids
Mandibular Injuries D008338 1 associated lipids
Diabetic Foot D017719 1 associated lipids
Bone Demineralization, Pathologic D018488 1 associated lipids
Emphysema D004646 1 associated lipids
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative D054438 1 associated lipids
Arteriolosclerosis D050379 1 associated lipids
Tooth Ankylosis D020254 1 associated lipids
Spondylarthropathies D025242 1 associated lipids
Legg-Calve-Perthes Disease D007873 1 associated lipids
Chondrocalcinosis D002805 1 associated lipids
Lymphangioleiomyomatosis D018192 1 associated lipids
Carcinoid Heart Disease D002275 1 associated lipids
Alphavirus Infections D018354 1 associated lipids
Jaw, Edentulous D007575 1 associated lipids
Foot Injuries D018409 1 associated lipids
Synovitis, Pigmented Villonodular D013586 1 associated lipids
Periostitis D010522 1 associated lipids
Prosthesis Failure D011475 1 associated lipids
Spondylarthritis D025241 1 associated lipids
Hyperphosphatemia D054559 1 associated lipids
Jaw, Edentulous, Partially D007576 1 associated lipids
Bone Diseases, Endocrine D001849 1 associated lipids
Vascular Calcification D061205 1 associated lipids
Angioid Streaks D000793 1 associated lipids
Atrial Remodeling D064752 1 associated lipids
Chondroblastoma D002804 1 associated lipids
Prediabetic State D011236 1 associated lipids
Tooth Resorption D014091 1 associated lipids
Hip Dislocation D006617 1 associated lipids
Malocclusion, Angle Class I D008311 1 associated lipids
Carcinoma, Neuroendocrine D018278 2 associated lipids
Bone Marrow Neoplasms D019046 2 associated lipids
Dermatomyositis D003882 2 associated lipids
Lymphocytosis D008218 2 associated lipids
Eye Neoplasms D005134 2 associated lipids
Radicular Cyst D011842 2 associated lipids
Lithiasis D020347 2 associated lipids
Labyrinthitis D007762 2 associated lipids
Cholesteatoma, Middle Ear D018424 2 associated lipids
Hypertension, Pregnancy-Induced D046110 2 associated lipids
Pasteurellaceae Infections D016871 2 associated lipids
Dental Pulp Calcification D003784 2 associated lipids
Musculoskeletal Diseases D009140 2 associated lipids
Bone Cysts, Aneurysmal D017824 2 associated lipids
Bone Diseases, Developmental D001848 2 associated lipids
Actinomycosis D000196 2 associated lipids
Adrenal Hyperplasia, Congenital D000312 2 associated lipids
Sarcoma, Ewing D012512 2 associated lipids
Osteophyte D054850 2 associated lipids
Root Resorption D012391 2 associated lipids
Pericardial Effusion D010490 2 associated lipids
Otosclerosis D010040 2 associated lipids
Prenatal Exposure Delayed Effects D011297 2 associated lipids
Gingival Recession D005889 2 associated lipids
Carcinoma, Medullary D018276 2 associated lipids
Foot Deformities, Acquired D005531 2 associated lipids
Tooth Migration D014085 2 associated lipids
Dengue D003715 2 associated lipids
Ossification, Heterotopic D009999 2 associated lipids
Hip Fractures D006620 2 associated lipids
No-Reflow Phenomenon D054318 2 associated lipids
Angina, Stable D060050 2 associated lipids
Fractures, Stress D015775 2 associated lipids
Osteosclerosis D010026 2 associated lipids
Urologic Neoplasms D014571 2 associated lipids
Tooth Mobility D014086 2 associated lipids
Bacteroidaceae Infections D016866 2 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Janda K et al. Osteoprotegerin as a marker of cardiovascular risk in patients on peritoneal dialysis. 2013 Pol. Arch. Med. Wewn. pmid:23535831
Tripuwabhrut P et al. Effect of compressive force on human osteoblast-like cells and bone remodelling: an in vitro study. 2013 Arch. Oral Biol. pmid:23583016
Recht M et al. The bone disease associated with factor VIII deficiency in mice is secondary to increased bone resorption. 2013 Haemophilia pmid:23731369
Wu X et al. Screening of osteoprotegerin-related feature genes in osteoporosis and functional analysis with DNA microarray. 2013 Eur. J. Med. Res. pmid:23731710
Araújo AA et al. Olmesartan decreases IL-1β and TNF-α levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitis. 2013 Naunyn Schmiedebergs Arch. Pharmacol. pmid:23775504
Rozas Moreno P et al. Serum osteoprotegerin: bone or cardiovascular marker in Type 2 diabetes males? 2013 J. Endocrinol. Invest. pmid:22391059
Crosley LK et al. The single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4 gene influences endothelial cell function: interaction with selenium and fatty acids. 2013 Mol Nutr Food Res pmid:23934705
Zhang J et al. Feeding blueberry diets to young rats dose-dependently inhibits bone resorption through suppression of RANKL in stromal cells. 2013 PLoS ONE pmid:23936431
Bezerra JP et al. Effects of estrogen deficiency and/or caffeine intake on alveolar bone loss, density, and healing: a study in rats. 2013 J. Periodontol. pmid:22873654
Yabumoto T et al. Stabilization of tooth movement by administration of reveromycin A to osteoprotegerin-deficient knockout mice. 2013 Am J Orthod Dentofacial Orthop pmid:23992809
Steagall WK et al. Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene. 2013 Am. J. Pathol. pmid:23867796
Anastasilakis AD et al. Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial. 2013 J. Clin. Endocrinol. Metab. pmid:23788684
Welldon KJ et al. Calcium induces pro-anabolic effects on human primary osteoblasts associated with acquisition of mature osteocyte markers. 2013 Mol. Cell. Endocrinol. pmid:23791847
Kato R et al. Gap-junction-mediated communication in human periodontal ligament cells. 2013 J. Dent. Res. pmid:23677649
Weng CH et al. [Effects of shangke jiegu tablet on the gene expressions of osteoprotegerin and osteoprotegerin ligand in the repairing process of mandibular defect rabbits]. 2013 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:23596799
Palumbo S and Li WJ Osteoprotegerin enhances osteogenesis of human mesenchymal stem cells. 2013 Tissue Eng Part A pmid:23597005
Liu CG et al. [Effect of Erigeron Breviscapus on the expression of OPG/RANKL/RANK in osteoblasts and pre-osteoclasts in vitro]. 2013 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:24517065
Owen S et al. Expression profile of receptor activator of nuclear-κB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. 2013 Anticancer Res. pmid:23267146
Lazzerini PE et al. Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells. 2013 Joint Bone Spine pmid:22999910
Feng ZY et al. Osteoprotegerin promotes the proliferation of chondrocytes and affects the expression of ADAMTS-5 and TIMP-4 through MEK/ERK signaling. 2013 Mol Med Rep pmid:24126801
Wang X et al. Effect of osteoprotegerin in combination with interleukin-6 on inhibition of osteoclast differentiation. 2013 Chin. J. Traumatol. pmid:24103822
Lotinun S et al. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. 2013 J. Clin. Invest. pmid:23321671
Saki F et al. Juvenile paget's disease in an Iranian kindred with vitamin D deficiency and novel homozygous TNFRSF11B mutation. 2013 J. Bone Miner. Res. pmid:23322328
Srivastava S et al. Role of vanadium (V) in the differentiation of C3H10t1/2 cells towards osteoblast lineage: a comparative analysis with other trace elements. 2013 Biol Trace Elem Res pmid:23325289
Mogelvang R et al. Osteoprotegerin improves risk detection by traditional cardiovascular risk factors and hsCRP. 2013 Heart pmid:23135978
Wolf M et al. Potential role of high mobility group box protein 1 and intermittent PTH (1-34) in periodontal tissue repair following orthodontic tooth movement in rats. 2013 Clin Oral Investig pmid:22777389
Deng YH et al. The influence of the genetic and non-genetic factors on bone mineral density and osteoporotic fractures in Chinese women. 2013 Endocrine pmid:22798246
Giganti MG et al. Changes in serum levels of TNF-alpha, IL-6, OPG, RANKL and their correlation with radiographic and clinical assessment in fragility fractures and high energy fractures. 2012 Oct-Dec J. Biol. Regul. Homeost. Agents pmid:23241117
Heitzer E et al. IL-7, IL-18, MCP-1, MIP1-β, and OPG as biomarkers for pain treatment response in patients with cancer. 2012 Nov-Dec Pain Physician pmid:23159968
Nuño-Arana I et al. Distribution of three SNPs related to low bone mineral density in Amerindian groups and Mestizos from Mexico. 2012 Jul-Aug Am. J. Hum. Biol. pmid:22434650
Varsavsky M et al. Serum osteoprotegerin and sex steroid levels in patients with prostate cancer. 2012 Jul-Aug J. Androl. pmid:21903971
Dalezis P et al. Dexamethasone plus octreotide regimen increases anticancer effects of docetaxel on TRAMP-C1 prostate cancer model. 2012 Jan-Feb In Vivo pmid:22210719
Ambroszkiewicz J et al. [Assessment of selected bone metabolism marker concentrations in children with cystic fibrosis]. 2012 Apr-Jun Med Wieku Rozwoj pmid:22971655
Wang N et al. Reduced bone turnover in mice lacking the P2Y13 receptor of ADP. 2012 Mol. Endocrinol. pmid:22108801
Boumans MJ et al. Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis. 2012 Ann. Rheum. Dis. pmid:22072013
Chen X et al. Cadmium stimulates the osteoclastic differentiation of RAW264.7 cells in presence of osteoblasts. 2012 Biol Trace Elem Res pmid:22076734
Bilgir O et al. Comparative levels of macrophage migration inhibitory factor, procalcitonin, osteoprotegerin, interleukin-8, hs-C reactive protein, D-dimer in febrile neutropenia, newly diagnosed cancer patients, and infectious fever. 2012 Transfus. Apher. Sci. pmid:22079264
Robinson DE et al. Glycosaminoglycan (GAG) binding surfaces for characterizing GAG-protein interactions. 2012 Biomaterials pmid:22079008
Rojano-Mejía D et al. TNFRSF11B gene haplotype and its association with bone mineral density variations in postmenopausal Mexican-Mestizo women. 2012 Maturitas pmid:22079369
Aliprantis AO et al. Transient muscle paralysis degrades bone via rapid osteoclastogenesis. 2012 FASEB J. pmid:22125315
Ueland T et al. TNF revisited: osteoprotegerin and TNF-related molecules in heart failure. 2012 Curr Heart Fail Rep pmid:22453763
Bogliolo L et al. Biomarkers and prognostic stratification in psoriatic arthritis. 2012 Reumatismo pmid:22690385
Olesen M et al. No influence of OPG and its ligands, RANKL and TRAIL, on proliferation and regulation of the calcification process in primary human vascular smooth muscle cells. 2012 Mol. Cell. Endocrinol. pmid:22698523
Cvija H et al. Chemotactic and immunoregulatory properties of bone cells are modulated by endotoxin-stimulated lymphocytes. 2012 Inflammation pmid:22699680
Kim H et al. Association between endometriosis and polymorphisms in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptor and osteoprotegerin genes and their serum levels. 2012 Arch. Gynecol. Obstet. pmid:22392486
Liu S et al. Effect of simvastatin on the osteogenetic behavior of alveolar osteoblasts and periodontal ligament cells. 2012 Hum. Cell pmid:22399266
Zhao NN et al. [Indication of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa B ligand (RANKL) in gingival crevicular fluid to remodeling of alveolar bone during retention]. 2012 Beijing Da Xue Xue Bao pmid:22353912
Zupan J et al. The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues. 2012 J. Biomed. Sci. pmid:22380539
Chai YC et al. Ectopic bone formation by 3D porous calcium phosphate-Ti6Al4V hybrids produced by perfusion electrodeposition. 2012 Biomaterials pmid:22381474
Hudson JB et al. Local delivery of recombinant osteoprotegerin enhances postorthodontic tooth stability. 2012 Calcif. Tissue Int. pmid:22382900
Singh DK et al. Prevalence and progression of peripheral vascular calcification in type 2 diabetes subjects with preserved kidney function. 2012 Diabetes Res. Clin. Pract. pmid:22386825
Jia P et al. The effect of alendronate on the expression of osteopontin and osteoprotegerin in calcified aortic tissue of the rat. 2012 Eur. J. Pharmacol. pmid:22387856
Zhang L et al. Effect of heat stress on the expression levels of receptor activator of NF-κB ligand and osteoprotegerin in human periodontal ligament cells. 2012 Int Endod J pmid:21899569
Hosbond SE et al. Osteoprotegerin as a marker of atherosclerosis: a systematic update. 2012 Scand. Cardiovasc. J. pmid:22506827
Fossmark R et al. Decreased bone mineral density and reduced bone quality in H(+) /K(+) ATPase beta-subunit deficient mice. 2012 J. Cell. Biochem. pmid:21882222
Oka H et al. Oral administration of prostaglandin E(2)-specific receptor 4 antagonist inhibits lipopolysaccharide-induced osteoclastogenesis in rat periodontal tissue. 2012 J. Periodontol. pmid:21910594
Wang JQ et al. [Effects of static magnetic field at different times on the proliferation and differentiation of osteoblasts in vitro]. 2012 Zhongguo Gu Shang pmid:23427595
Altan BA et al. Metrical and histological investigation of the effects of low-level laser therapy on orthodontic tooth movement. 2012 Lasers Med Sci pmid:21038101
Chen WH et al. Effects of huogu I formula (I) on correlated factors of bone regeneration in chickens with steroid-induced necrosis of femoral head. 2012 Chin J Integr Med pmid:22549392
Zheng D et al. The beneficial effect of Icariin on bone is diminished in osteoprotegerin-deficient mice. 2012 Bone pmid:22551876
Lee JW et al. Coptisine inhibits RANKL-induced NF-κB phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells. 2012 J Nat Med pmid:21656335
Wang YD et al. Selective regulation of osteoblastic OPG and RANKL by dehydroepiandrosterone through activation of the estrogen receptor β-mediated MAPK signaling pathway. 2012 Horm. Metab. Res. pmid:22556124
Larussa T et al. No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease. 2012 World J. Gastroenterol. pmid:22529691
Niu YB et al. The beneficial effect of Radix Dipsaci total saponins on bone metabolism in vitro and in vivo and the possible mechanisms of action. 2012 Osteoporos Int pmid:22535190
Hou JM et al. Bovine lactoferrin improves bone mass and microstructure in ovariectomized rats via OPG/RANKL/RANK pathway. 2012 Acta Pharmacol. Sin. pmid:22902986
Ma B et al. Strontium fructose 1,6-diphosphate prevents bone loss in a rat model of postmenopausal osteoporosis via the OPG/RANKL/RANK pathway. 2012 Acta Pharmacol. Sin. pmid:22426695
García-Martín A et al. [Effect of milk product with soy isoflavones on quality of life and bone metabolism in postmenopausal Spanish women: randomized trial]. 2012 Med Clin (Barc) pmid:22024564
Zijlstra WP et al. Cobalt and chromium ions reduce human osteoblast-like cell activity in vitro, reduce the OPG to RANKL ratio, and induce oxidative stress. 2012 J. Orthop. Res. pmid:22025323
Zhao N et al. Effects of local osteoprotegerin gene transfection on orthodontic root resorption during retention: an in vivo micro-CT analysis. 2012 Orthod Craniofac Res pmid:22264323
Erkol A et al. Plasma osteoprotegerin level on admission is associated with no-reflow phenomenon after primary angioplasty and subsequent left ventricular remodeling in patients with acute ST-segment elevation myocardial infarction. 2012 Atherosclerosis pmid:22265272
Martin CK et al. Characterization of bone resorption in novel in vitro and in vivo models of oral squamous cell carcinoma. 2012 Oral Oncol. pmid:22265717
Reginster JY et al. Strontium ranelate treatment increases osteoprotegerin serum levels in postmenopausal osteoporotic women. 2012 Bone pmid:22270053
Dong W et al. [Effect of alendronate on expressions of osteoprotegerin and receptor activator of nuclear factor κB ligand in mouse osteoblasts]. 2012 Nan Fang Yi Ke Da Xue Xue Bao pmid:23268391
Feng Y et al. AMP-activated protein kinase acts as a negative regulator of high glucose-induced RANKL expression in human periodontal ligament cells. 2012 Chin. Med. J. pmid:22964327
Pedersen S et al. Osteoprotegerin predicts long-term outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. 2012 Cardiology pmid:22964478
Bargman R et al. High- and low-dose OPG-Fc cause osteopetrosis-like changes in infant mice. 2012 Pediatr. Res. pmid:22926546
Cauley JA Commentary: A single biomarker in a complex metabolic pathway. 2012 Int J Epidemiol pmid:22933649
Deuell KA et al. RANKL enhances macrophage paracrine pro-calcific activity in high phosphate-treated smooth muscle cells: dependence on IL-6 and TNF-α. 2012 J. Vasc. Res. pmid:22948607
Li F et al. Echinacoside promotes bone regeneration by increasing OPG/RANKL ratio in MC3T3-E1 cells. 2012 Fitoterapia pmid:22951288
Guo D et al. Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer. 2012 Mol. Cell. Biochem. pmid:22167620
Svensson M et al. Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study. 2012 Nephrol. Dial. Transplant. pmid:22172725
Kraus D et al. Intermittent PTH(1-34) signals through protein kinase A to regulate osteoprotegerin production in human periodontal ligament cells in vitro. 2012 Clin Oral Investig pmid:22186940
Zhao N et al. Local osteoprotegerin gene transfer inhibits relapse of orthodontic tooth movement. 2012 Am J Orthod Dentofacial Orthop pmid:22196183
Chen J et al. OPG inhibits gene expression of RANK and CAII in mouse osteoclast-like cell. 2012 Rheumatol. Int. pmid:22210270
Giannopoulou C et al. Immunohistochemical expression of RANKL, RANK and OPG in gingival tissue of patients with periodontitis. 2012 Acta Odontol. Scand. pmid:22214279
Bloch SL and Sørensen MS Otosclerosis: a perilabyrinthine threshold phenomenon. 2012 Acta Otolaryngol. pmid:22217131
Li YL and Wang H [Serum osteoprotegerin level in children with nephrotic syndrome and the effect of glucocorticoid on it]. 2012 Zhongguo Dang Dai Er Ke Za Zhi pmid:22989431
Kim IS et al. Human mesenchymal stromal cells are mechanosensitive to vibration stimuli. 2012 J. Dent. Res. pmid:23086742
Xu Y et al. [The function of bushen qiangdu recipe containing serum in OPG/RANKL pathway of ankylosing spondylitis patients]. 2012 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:22803436
Zhu XF et al. [Effects of yigu capsule containing serum on the osteoblast differentiation and the expressions of osteoprotegerin and bone morphogenetic protein 2 after treatment by advanced glycation end products in vitro]. 2012 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:22803437
Nyrnes A et al. Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: the Tromsø study. 2012 Gend Med pmid:23046763
Davenport C et al. The effect of exercise on osteoprotegerin and TNF-related apoptosis-inducing ligand in obese patients. 2012 Eur. J. Clin. Invest. pmid:22803952
Brandenburg V et al. Calcification inhibitors in vascular calciphylaxis associated with normal renal function. 2012 Thromb. Haemost. pmid:23092963
Histing T et al. Melatonin impairs fracture healing by suppressing RANKL-mediated bone remodeling. 2012 J. Surg. Res. pmid:20888595
Mirzaei K et al. Potential role of OPG/RANKL system and FokI genotypes in pathogenesis and clinical manifestations in multiple sclerosis. 2012 Minerva Med. pmid:22805623
Ryser MD et al. Osteoprotegerin in bone metastases: mathematical solution to the puzzle. 2012 PLoS Comput. Biol. pmid:23093918
Kleyer A et al. Liver X receptors orchestrate osteoblast/osteoclast crosstalk and counteract pathologic bone loss. 2012 J. Bone Miner. Res. pmid:22806960
Wang C et al. Susceptibility genes for osteoporotic fracture in postmenopausal Chinese women. 2012 J. Bone Miner. Res. pmid:22807154
Poerschke RL et al. Major differences among chemopreventive organoselenocompounds in the sustained elevation of cytoprotective genes. 2012 J. Biochem. Mol. Toxicol. pmid:22807314
Tenta R et al. Association between circulating levels of adiponectin and indices of bone mass and bone metabolism in middle-aged post-menopausal women. 2012 J. Endocrinol. Invest. pmid:21606670

Table of Content